113 related articles for article (PubMed ID: 21195165)
1. Targeting the hematopoietic system for the treatment of Alzheimer's disease.
Lampron A; Gosselin D; Rivest S
Brain Behav Immun; 2011 Jun; 25 Suppl 1():S71-9. PubMed ID: 21195165
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.
Simard AR; Soulet D; Gowing G; Julien JP; Rivest S
Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.
Simard AR; Rivest S
Mol Psychiatry; 2006 Apr; 11(4):327-35. PubMed ID: 16491130
[TBL] [Abstract][Full Text] [Related]
4. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
5. [Current trend of immunotherapy for Alzheimer's disease].
Matsumoto SE; Tabira T
Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
[TBL] [Abstract][Full Text] [Related]
6. Bone-marrow-derived microglia: myth or reality?
Soulet D; Rivest S
Curr Opin Pharmacol; 2008 Aug; 8(4):508-18. PubMed ID: 18487084
[TBL] [Abstract][Full Text] [Related]
7. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease.
Malm TM; Magga J; Kuh GF; Vatanen T; Koistinaho M; Koistinaho J
Glia; 2008 Dec; 56(16):1767-79. PubMed ID: 18649403
[TBL] [Abstract][Full Text] [Related]
8. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
9. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
10. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model.
Butovsky O; Kunis G; Koronyo-Hamaoui M; Schwartz M
Eur J Neurosci; 2007 Jul; 26(2):413-6. PubMed ID: 17623022
[TBL] [Abstract][Full Text] [Related]
11. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
12. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
16. Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice.
Pimentel-Coelho PM; Michaud JP; Rivest S
Neurobiol Aging; 2013 Mar; 34(3):679-93. PubMed ID: 22819135
[TBL] [Abstract][Full Text] [Related]
17. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint.
Marx F; Blasko I; Grubeck-Loebenstein B
Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867
[TBL] [Abstract][Full Text] [Related]
19. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden.
Kellner A; Matschke J; Bernreuther C; Moch H; Ferrer I; Glatzel M
Ann Neurol; 2009 Jan; 65(1):24-31. PubMed ID: 19194878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
